CG
VTYX

Cutler Group’s Ventyx Biosciences VTYX Stock Holding History

Cutler Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$2K – 4420
2023
Q3 		$2K Buy
+500
New +$17.3K ﹤0.01% 3372
2023
Q2 		– Sell
-2,900
Closed -$3K – 4243
2023
Q1 		$3K Buy
2,900
+2,200
+314% +$85.5K ﹤0.01% 3045
2022
Q4 		$2K Sell
700
-1,000
-59% -$29.6K ﹤0.01% 3810
2022
Q3 		$2K Buy
+1,700
New +$37.6K ﹤0.01% 4329

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cutler Group's VTYX Position: Q1 2024 in Review

Cutler Group reduced its Ventyx Biosciences (VTYX) stake by 22% in Q1 2024, selling an estimated $2.29K and leaving 1,800 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Cutler Group first reported a position in VTYX in Q3 2022 and has held it in 6 quarters since. The position peaked at $22K in Q2 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Cutler Group held 1,800 shares of Ventyx Biosciences worth $9K as of Q1 2024.
  • Cutler Group sold 500 Ventyx Biosciences shares in Q1 2024, an estimated $2.29K.
  • Ventyx Biosciences made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1350 holding.
  • Cutler Group first reported a position in Ventyx Biosciences in Q3 2022 and has held it in 6 quarters since.
  • Cutler Group's Ventyx Biosciences position peaked at $22K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.